Patent · US Active

Stable formulations for lyophilizing therapeutic particles

US8956657B2 · kind B2 · utility

1Cited by
38References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2013
Grant dateFeb 17, 2015
Priority date
Expiry dateApr 12, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.